New guidelines for optimal patient care with localized colon cancer: recommending what is proven, but also watching what research is bringing.

Tarazona, N; Roda, D; Roselló, S; Huerta, M; Cervantes, A

Tarazona, N; Roda, D; Roselló, S; Huerta, M; Cervantes, A.

Affiliation

Tarazona N; Department of Medical Oncology, Biomedical Research Institute INCLIVA, University of Valencia, Valencia, Spain; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.
Roda D; Department of Medical Oncology, Biomedical Research Institute INCLIVA, University of Valencia, Valencia, Spain; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.
Roselló S; Department of Medical Oncology, Biomedical Research Institute INCLIVA, University of Valencia, Valencia, Spain; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.
Huerta M; Department of Medical Oncology, Biomedical Research Institute INCLIVA, University of Valencia, Valencia, Spain.
Cervantes A; Department of Medical Oncology, Biomedical Research Institute INCLIVA, University of Valencia, Valencia, Spain; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain. Electronic address: andres.cervantes@uv.es.

Ann Oncol ; 31(10): 1287-1288, 2020 10.

Article de En | MEDLINE | ID: mdl-32710931

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs du côlon Type d'étude: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Humans Langue: En Journal: Ann Oncol Sujet du journal: NEOPLASIAS Année: 2020 Type de document: Article Pays d'affiliation: Espagne

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google